Geode Capital Management
BHVN

Geode Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Geode Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,097,362
Closed -$166M – 5090
2022
Q3 		$166M Buy
1,097,362
+25,237
+2% +$3.74M 0.03% 528
2022
Q2 		$156M Buy
1,072,125
+67,512
+7% +$8.62M 0.02% 545
2022
Q1 		$119M Buy
1,004,613
+43,523
+5% +$5.43M 0.01% 688
2021
Q4 		$132M Buy
961,090
+22,116
+2% +$2.81M 0.02% 689
2021
Q3 		$130M Buy
938,974
+25,524
+3% +$3.19M 0.02% 666
2021
Q2 		$88.7M Buy
913,450
+96,911
+12% +$7.87M 0.01% 864
2021
Q1 		$55.8M Buy
816,539
+79,943
+11% +$6.47M 0.01% 1138
2020
Q4 		$63.1M Buy
736,596
+43,886
+6% +$3.72M 0.01% 952
2020
Q3 		$45M Buy
692,710
+36,174
+6% +$2.37M 0.01% 976
2020
Q2 		$48M Buy
656,536
+49,845
+8% +$2.65M 0.01% 918
2020
Q1 		$20.6M Buy
606,691
+88,876
+17% +$4.06M 0.01% 1271
2019
Q4 		$28.2M Buy
517,815
+195
+0% +$9.66K 0.01% 1335
2019
Q3 		$21.6M Buy
517,620
+43,520
+9% +$1.84M 0.01% 1428
2019
Q2 		$20.8M Buy
474,100
+80,514
+20% +$4.54M 0.01% 1453
2019
Q1 		$20.3M Buy
393,586
+39,939
+11% +$1.73M 0.01% 1411
2018
Q4 		$13.1M Buy
353,647
+82,960
+31% +$2.99M ﹤0.01% 1593
2018
Q3 		$10.2M Buy
270,687
+17,625
+7% +$648K ﹤0.01% 1905
2018
Q2 		$10M Buy
253,062
+75,604
+43% +$2.4M ﹤0.01% 1863
2018
Q1 		$4.57M Buy
177,458
+5,350
+3% +$160K ﹤0.01% 2290
2017
Q4 		$4.64M Buy
172,108
+20,908
+14% +$576K ﹤0.01% 2251
2017
Q3 		$5.65M Sell
151,200
-13,704
-8% -$416K ﹤0.01% 2125
2017
Q2 		$4.12M Buy
+164,904
New +$3.8M ﹤0.01% 2283

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Geode Capital Management's BHVN Position: Q4 2022 in Review

Geode Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,097,362 shares — an estimated $166M sold.

Geode Capital Management first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $166M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Geode Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Geode Capital Management sold 1,097,362 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $166M.
  • Geode Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Geode Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $166M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.